Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer ResectionJohn P. Neoptolemos, for the European Study Group for Pancreatic Cancer, C. Mariette et al.|JAMA|2010Cited by 1.4k
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportAlicia Okines, David Cunningham, Ruth E. Langley et al.|Annals of Oncology|2012Cited by 67
A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3).Tom Samuel Waddell, David Cunningham, Ian Chau et al.|Journal of Clinical Oncology|2012Cited by 49
Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trialsAlicia Okines, Andrew Wotherspoon, David González de Castro et al.|European Journal of Cancer|2013Cited by 40
Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox et al.|Journal of Clinical Oncology|2011Cited by 24